EPrints@IIT Delhi >
Faculty Research Publicatons  >
Biomedical Engineering [CBME] >

Please use this identifier to cite or link to this item: http://eprint.iitd.ac.in/handle/2074/593

Title: Two-year clinical efficacy trial with dose variations of a vas deferens injectable contraceptive for the male
Authors: Guha, Sujoy K
Singh, Gulshanjit
Srivastava, Anil
Das, H C
Bhardwaj, J C
Mathur, Vineet
Koul, Veena
Malhotra, R L
Das, S K
Keywords: single injection
vas deferens
pregnancy protection
libido maintenance
Issue Date: 1998
Citation: Contraception, 58(3), 165–174
Abstract: Contraceptive action of a single intra–vas deferens injection of a specific preparation of styrene maleic anhydride (SMA) dissolved in dimethyl sulphoxide, forming a drug given the name Risugt, has been demonstrated earlier.Now fertility control over a 2-year period with doses having the SMA component ranging from 40 to 70 mg is reported here. The results suggest that pregnancy protection is obtained both in the azoospermic and non-azoospermic states. Side effects are minimal and transient in nature. Libido remains unaltered.
URI: http://eprint.iitd.ac.in/dspace/handle/2074/593
Appears in Collections:Biomedical Engineering [CBME]

Files in This Item:

File Description SizeFormat
guhatwo1998.pdf1.96 MBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback